1. 2020
  2. Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice

    Colemonts-Vroninks, H., Norman, B., Davison, A., Neuckermans, J., Marcélis, L., Mortier, A., De Bundel, D., Ranganath, L., Martens, G., Vanhaecke, T., Gallagher, J. & De Kock, J., 17 Apr 2020, p. FRI284.

    Research output: Unpublished contribution to conferencePoster

  3. The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells.

    Buyl, K., Merimi, M., Rodrigues, R., Agha, D. M., Melki, R., Vanhaecke, T., Bron, D., Lewalle, P., Meuleman, N., Fahmi, A. H., Rogiers, V., Lagneaux, L. & De Kock, J., 3 Apr 2020, In : Journal of Clinical Medicine. E696, 9, 9(3).

    Research output: Contribution to journalArticle

  4. Directed protein evolution as a tool to innovate gene therapy for hereditary tyrosinemia type 1

    Neuckermans, J., Colemonts-Vroninks, H., Marcélis, L., Mertens, A., Schwaneberg, U. & De Kock, J., Mar 2020.

    Research output: Unpublished contribution to conferencePoster

  5. 2019
  6. Anti-NASH Drug Development Hitches a Lift on PPAR Agonism

    Boeckmans, J., Natale, A., Rombaut, M., Buyl, K., Rogiers, V., De Kock, J., Vanhaecke, T. & Rodrigues, R., 21 Dec 2019, In : Cells. 9, 1, p. 1-20 20 p., 37.

    Research output: Contribution to journalArticle

  7. Large‐scale Production of LGR5‐positive Bipotential Human Liver Stem Cells

    Schneeberger, K., Sánchez‐Romero, N., Ye, S., van Steenbeek, F. G., Oosterhoff, L. A., Pla Palacin, I., Chen, C., van Wolferen, M. E., van Tienderen, G., Lieshout, R., Colemonts-Vroninks, H., Schene, I., Hoekstra, R., Verstegen, M. M. A., van der Laan, L. J. W., Penning, L. C., Fuchs, S. A., Clevers, H., De Kock, J., Baptista, P. M. & 1 others, Spee, B., 12 Nov 2019, (Accepted/In press) In : Hepatology.

    Research output: Contribution to journalArticle

  8. A robust bacterial assay for high-throughput screening of human 4-hydroxyphenylpyruvate dioxygenase inhibitors

    Neuckermans, J., Mertens, A., Schwaneberg, U. & De Kock, J., 2 Oct 2019, In : Scientific Reports. 9, 1, p. 14145 11 p.

    Research output: Contribution to journalArticle

  9. Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists

    Boeckmans, J., Rombaut, M., Natale, A., Buyl, K., Rogiers, V., De Kock, J., Vanhaecke, T. & Rodrigues, R., 1 Oct 2019, Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists. p. 1290A-1291A 2 p.

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)

  10. Transcriptomics data of a human in vitro model of non-alcoholic steatohepatitis exposed to elafibranor

    Boeckmans, J., Buyl, K., Natale, A., Vandenbempt, V., Branson, S., De Boe, V., Rogiers, V., De Kock, J., Marcelino Rodrigues, R. & Vanhaecke, T., 1 Aug 2019, In : Data in Brief. 25, p. 104093 6 p., 104093.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 109517